News

Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.
Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...
Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with WeightWatchers to ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...
SoftBank's Son Lays Out Vision to Be No. 1 in Artificial Superintelligence SoftBank's investment plans have come under scrutiny as Japan tries to close a deal with the Trump administration. There's a ...
Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...